Companies: 10,795·Total market cap: $144.5T
Aoxing Pharmaceutical Company, Inc.

Aoxing Pharmaceutical Company, Inc.

AOXGOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$320107
P/E Ratio
52W High$0.0107
52W Low$0.0016

Aoxing Pharmaceutical Company, Inc. (AOXG) Revenue

Annual & quarterly revenue history · segment & region breakdown

AOXG · revenue · updated Jun 10, 2026

Core revenue metrics

Aoxing Pharmaceutical Company, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
16.59×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$0K
346 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Aoxing Pharmaceutical Company, Inc. SEC filings · GAAPUpdated: 2026-06-10

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
AOXG revenue by year · AOXG revenue history · AOXG annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Aoxing Pharmaceutical Company, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Aoxing Pharmaceutical Company, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Aoxing Pharmaceutical Company, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

AOXG revenue · 4 questions

AOXG's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

AOXG revenueAOXG annual revenuewhat is AOXG revenueAOXG TTM revenue

Source: FMP · Aoxing Pharmaceutical Company, Inc. SEC filings · GAAP · Aoxing Pharmaceutical Company, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026